Interests of charities: Arthritis care sets facts straightBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7410.344-a (Published 07 August 2003) Cite this as: BMJ 2003;327:344
- William Butler (WilliamB@arthritiscare.org.uk), chief executive,
- David Doyle, consultant rheumatologist,
- Richard Hull, consultant rheumatologist
- Arthritis Care, London NW1 2HD
EDITOR—We acknowledge Hirst's genuine concern about the relation between medical charities and pharmaceutical companies,1 but we here address some important factual inaccuracies in her letter.
Firstly, in 2002 Arthritis Care launched an information campaign to promote the government's National Institute for Clinical Excellence (NICE) guidance on cyclooxygenase-2 (COX 2) inhibitors, which were found to hold potential benefits for some people with arthritis. …